Cannabis, CBD, THC & Hemp Regulations in Africa by Region & Priority Countries (2026)

Research date: 26 September 2026

This article provides regional overviews and focused summaries of the most active cannabis, CBD, THC and industrial hemp jurisdictions in Africa. It is designed as a companion to the main Africa-wide regulatory guide and serves as a foundation for dedicated country and regional pages on CBDAfrica.com.

Africa is not a single legal market. Regulatory approaches differ sharply between regions and between individual countries. This guide highlights the main patterns in North, West, Central, East and Southern Africa, followed by detailed snapshots of eight priority countries that currently attract the greatest industry, research and policy interest.

Disclaimer: This is general informational content only. It does not constitute legal, medical or investment advice. Laws change. Always verify the current position with the relevant national authority or qualified local counsel before taking any action.

Regional Overview

Southern Africa

Southern Africa is the most developed region for regulated cannabis and hemp activity. Several countries operate licensed medical and industrial frameworks focused primarily on export, while South Africa is the only jurisdiction on the continent that constitutionally protects private adult use and home cultivation.

Key characteristics:

• Licensed medical cannabis cultivation and export in Lesotho, Zimbabwe, Malawi, South Africa, Botswana and Zambia.
• Industrial hemp programmes with defined THC thresholds (South Africa 2 %, Zimbabwe 1 %, Zambia 0.3 %, Botswana 0.7 %).
• South Africa’s unique private-use protection under the Cannabis for Private Purposes Act 2024 (draft regulations published 2026).
• Strong emphasis on export markets, GMP/GACP standards and international compliance.
• Domestic patient access and recreational commercial sales remain limited or prohibited.

Southern Africa continues to lead the continent in regulatory innovation and commercial activity, although implementation quality and licensing costs vary significantly between countries.

North Africa

North Africa is dominated by strict prohibition outside Morocco. Morocco is the clear regional leader following the 2021 adoption of Law 13-21, which authorised licensed cultivation, processing and trade of cannabis for medical, pharmaceutical, cosmetic and industrial purposes under the National Agency for the Regulation of Activities relating to Cannabis (ANRAC).

Key characteristics:

• Morocco: Licensed medical and industrial cannabis in designated provinces; expanding product range including cosmetics; recreational use remains prohibited.
• Algeria, Egypt, Libya, Tunisia, Mauritania: Comprehensive prohibition of cannabis, CBD and hemp activity with limited or no public licensing pathways.
• Focus in Morocco is on formalising traditional cultivation areas, export and gradual development of domestic medical products.

Outside Morocco, reliable public information on any form of authorised cannabis activity remains extremely limited.

West Africa

West Africa is characterised by strict drug-control regimes, with Ghana emerging as the most progressive jurisdiction. Most countries maintain full prohibition aligned with UN conventions.

Key characteristics:

• Ghana: Narcotics Control Commission Act framework allowing licensed cultivation of cannabis with ≤ 0.3 % THC for medicinal and industrial purposes; first cultivation licences issued in 2026.
• Nigeria: Strict prohibition under NDLEA and NAFDAC oversight; limited public progress on medical or industrial programmes.
• Other countries (Senegal, Côte d’Ivoire, Mali, Burkina Faso, Benin, Togo, Guinea, Sierra Leone, Liberia, The Gambia, Guinea-Bissau, Cabo Verde): Generally prohibit unauthorised cannabis activity; little verified public licensing activity.

Ghana is currently the primary point of interest for industry observers in the region.

East Africa

East Africa shows a mixed picture. Uganda and Rwanda have taken steps toward regulated medical and industrial activity, while Kenya and Tanzania remain more restrictive.

Key characteristics:

• Uganda: Industrial Hemp Regulations 2020 and licensed medical/export pathways under the National Drug Authority; experimental medical cultivation licences issued.
• Rwanda: Advancing commercial production of cannabis for medical and pharmaceutical purposes (2026 policy developments); recreational use remains illegal.
• Kenya: Strict prohibition; limited public progress on formal medical or industrial frameworks.
• Tanzania, Ethiopia, Somalia, Djibouti, Eritrea, South Sudan, Burundi: Predominantly prohibitive regimes with scarce public licensing information.

Uganda and Rwanda are the jurisdictions attracting the most attention for future development.

Central Africa

Central Africa remains the least developed region for regulated cannabis or hemp activity. Almost all countries maintain comprehensive prohibition with minimal public information on any licensed pathways.

Key characteristics:

• Democratic Republic of the Congo, Republic of the Congo, Cameroon, Gabon, Equatorial Guinea, Central African Republic, Chad, São Tomé and Príncipe: Strict drug-control laws; no verified operational medical or industrial cannabis programmes of significant scale.
• Public regulatory transparency is generally low.

Central Africa currently offers the fewest verified commercial or research opportunities in the regulated cannabis and hemp space.

Priority Country Snapshots

The following eight countries currently attract the greatest interest from researchers, businesses, farmers and policymakers. Each summary is intentionally concise and directs readers toward dedicated country guides for deeper analysis.

South Africa

Status (September 2026): Most advanced dual framework on the continent.

• Private adult possession, use and limited home cultivation protected (Cannabis for Private Purposes Act 2024; draft quantity regulations published February 2026).
• Commercial recreational sale remains prohibited.
• Medical cannabis: Licensed via SAHPRA (section 22C).
• Industrial hemp: Plant Improvement Act 11 of 2018 (commenced 1 December 2025) – THC threshold raised to 2 % in leaves and flowering heads; cultivation permits available.
• CBD: Limited historical exemption for low-dose products; broader consumer rules still evolving.
• Main regulators: SAHPRA, Department of Agriculture, Department of Justice.

South Africa is the only African country with constitutional private-use protection and the highest operational hemp THC threshold.

Lesotho

Status: Pioneer of licensed medical cannabis cultivation in Africa (first licences ≈ 2017).

• Recreational use prohibited.
• Medical and scientific cultivation, manufacturing and export under licence.
• 2025 Drugs of Abuse (Cannabis) Amendment Regulations significantly increased licence fees and tightened import/export and testing requirements.
• Focus remains heavily export-oriented; domestic patient access is limited.
• Main regulators: Lesotho Medicines Regulatory Authority (LeMeRA), Lesotho Narcotics Bureau, Ministry of Health.

Lesotho continues to refine its high-compliance, export-focused model.

Zimbabwe

Status: Established dual medical and industrial hemp frameworks.

• Recreational use prohibited.
• Medical cannabis: Statutory Instrument 62 of 2018 (updated 2026) – cultivation and production licences for medicinal and scientific use (primarily export).
• Industrial hemp: ≤ 1 % THC threshold; separate licensing under agricultural authorities.
• CBD products fall under medical/industrial rules; residual THC limits apply.
• Main regulators: Medicines Control Authority of Zimbabwe (MCAZ), Ministry of Lands, Agriculture, Fisheries, Water and Rural Resettlement.

Zimbabwe offers one of the more mature dual-track systems in Southern Africa.

Uganda

Status: Emerging medical and industrial hemp jurisdiction.

• Recreational use prohibited.
• Industrial hemp regulated under 2020 regulations.
• Licensed medical/export cultivation possible; experimental licences have been issued.
• High capital and security requirements reported for medical projects.
• Main regulators: National Drug Authority, Ministry of Health, Ministry of Agriculture.

Uganda is building capacity but remains early-stage compared with Southern African peers.

Ghana

Status: Leading West African jurisdiction for regulated low-THC cannabis.

• Recreational use prohibited.
• Licensed cultivation of cannabis with ≤ 0.3 % THC for medicinal and industrial purposes under the Narcotics Control Commission Act.
• First cultivation licences formally issued in 2026.
• Strong emphasis on research partnerships (e.g. with CSIR) and strict compliance.
• Main regulator: Narcotics Control Commission (NACOC).

Ghana is the primary West African market currently open to licensed activity.

Nigeria

Status: Strict prohibition with limited public progress.

• Recreational, medical and industrial cannabis activity remains heavily restricted under NDLEA and NAFDAC oversight.
• No operational large-scale licensed medical or industrial hemp programme verified in public sources as of September 2026.
• Policy discussions occur periodically, but concrete licensing frameworks are not yet in force at scale.
• Main regulators: National Drug Law Enforcement Agency (NDLEA), National Agency for Food and Drug Administration and Control (NAFDAC).

Nigeria remains a high-interest market for future reform, but current opportunities are extremely limited.

Kenya

Status: Restrictive regime with limited verified licensing pathways.

• Recreational use prohibited.
• Public information on formal medical or industrial cannabis programmes remains sparse.
• Any authorised activity would fall under health and pharmacy regulators, but large-scale licensed cultivation is not currently operational.
• Main regulators: Pharmacy and Poisons Board, Ministry of Health.

Kenya is frequently discussed in regional conversations but has not yet established a mature licensed industry.

Morocco

Status: Leading North African jurisdiction and one of the continent’s most structured programmes.

• Recreational use remains prohibited under the 1974 Dahir.
• Law 13-21 (2021) authorises licensed cultivation, processing, manufacturing, trade and export for medical, pharmaceutical, cosmetic and industrial purposes.
• National Agency for the Regulation of Activities relating to Cannabis (ANRAC) oversees the sector.
• Cultivation restricted to designated provinces; thousands of farmer authorisations issued; product range expanding (including cosmetics).
• THC threshold for industrial varieties set at 1 %.

Morocco combines traditional cultivation expertise with a modern regulatory agency and growing product diversification.

Key Takeaways for Stakeholders

• Southern Africa currently offers the greatest concentration of operational licensed frameworks.
• Morocco is the standout in North Africa.
• Ghana is the most advanced in West Africa.
• Uganda and Rwanda are the main points of progress in East Africa.
• Central Africa remains largely closed.
• No African country has legalised commercial recreational cannabis sales.
• Export-oriented medical and industrial models dominate licensed activity.
• Domestic consumer markets for CBD and cannabis products are still heavily restricted almost everywhere.

How to Use This Guide

This regional and priority-country overview is intended as a navigation tool. Readers seeking detailed legal analysis, licence requirements, THC thresholds, product rules or recent legislative changes should consult the dedicated country and regional pages that will form the next layer of the CBDAfrica.com regulatory database.

Recommended next steps:

• Read the full Africa-wide overview for comparative tables and methodology.
• Visit individual country guides for South Africa, Lesotho, Zimbabwe, Uganda, Ghana, Nigeria, Kenya and Morocco.
• Monitor regional guides for North, West, Central, East and Southern Africa as they are published.

Medical disclaimer: Information relating to CBD and cannabis is provided for general educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Legal disclaimer: Cannabis, CBD, THC and hemp laws vary by country and change over time. This content is for general information only and does not constitute legal advice. Verify all requirements with the relevant government authority or a qualified legal professional before taking any action.

CBDAfrica.com is building a continuously updated African Cannabis, CBD, THC & Hemp Regulatory Database. This article forms part of the regional and priority-country layer of that resource. Last verified: 26 September 2026.